Genmab A/S Files March 2025 6-K Report
Ticker: GNMSF · Form: 6-K · Filed: Mar 20, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, registration-statement
TL;DR
Genmab filed its March 6-K, nothing major but it's now part of their S-8 filings.
AI Summary
Genmab A/S filed a Form 6-K on March 20, 2025, to report information for the month of March 2025. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File No. 333-284876.
Why It Matters
This filing serves as an update for investors and indicates ongoing reporting requirements for Genmab A/S, a Danish pharmaceutical company.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previous information into registration statements, with no new material financial or operational data disclosed.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — S-8 Registration Statement File Number
- 333-253519 (dollar_amount) — S-8 Registration Statement File Number
- 333-262970 (dollar_amount) — S-8 Registration Statement File Number
- 333-277273 (dollar_amount) — S-8 Registration Statement File Number
- 333-284876 (dollar_amount) — S-8 Registration Statement File Number
FAQ
What type of filing is this for Genmab A/S?
This is a Form 6-K report of Foreign Private Issuer.
What period does this 6-K report cover?
The report is for the month of March 2025.
What is the filing date of this report?
The filing date is March 20, 2025.
Which registration statements does this 6-K filing get incorporated into?
This filing is incorporated by reference into Genmab A/S's registration statements on Form S-8, specifically File Numbers 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What is the principal executive office address for Genmab A/S?
The address is Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 20, 2025 regarding GENMAB A/S (GNMSF).